AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
Thursday, April 21, 2016 - 19:10
in Biology & Nature
CAMBRIDGE, England (Reuters) - AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines.